Pearson-Stuttard Jonathan, Chan Mei Sum, Holloway Sara, Sommer Matthiessen Kasper, Thompson Andrew, Capucci Silvia
Health Analytics, Lane Clark & Peacock LLP, London, UK.
Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Diabetes Obes Metab. 2025 May;27(5):2690-2697. doi: 10.1111/dom.16271. Epub 2025 Feb 26.
Obesity and its complications contribute to the burden of cardiovascular disease (CVD). Here, we characterised individuals with high body mass index (BMI) and established CVD by assessing healthcare resource utilisation (HCRU) and costs, incidence of cardiovascular (CV) events and mortality.
This was a retrospective open cohort study using UK Discover data (study period: January 2004 to December 2019). Included were individuals aged ≥45 years with BMI ≥ 27 kg/m, without type 1 or type 2 diabetes, and with established CVD (previous myocardial infarction, stroke or peripheral artery disease). Serial annual cross sections were assembled to generate prevalence and incidence cohorts and for mapping of HCRU, costs and the incidence of selected events. CVD and mortality trajectories were modelled using a Markov model. HCRU and costs were layered onto this model to obtain associated trajectories.
In 2019, annual per-person healthcare costs for individuals with high BMI and established CVD (n = 27 313) were £3364. During 2015-2019, the incidence of major adverse CV events was 2812 per 100,000 person-years; the incidences of all-cause and CV mortality were 2896 and 774 per 100,000 person-years, respectively. Over 2022-2031, this population is projected to accrue estimated healthcare costs of £40.8 million. HCRU trajectory drivers included a history of CV events, older age, and multimorbidity.
Owing to a high disease and treatment burden, people with a history of CVD living with high BMI incur substantial healthcare costs and are at risk of mortality.
肥胖及其并发症加重了心血管疾病(CVD)的负担。在此,我们通过评估医疗资源利用(HCRU)、成本、心血管(CV)事件发生率和死亡率,对高体重指数(BMI)且已确诊CVD的个体进行了特征描述。
这是一项回顾性开放队列研究,使用英国发现数据(研究期:2004年1月至2019年12月)。纳入的个体年龄≥45岁,BMI≥27 kg/m²,无1型或2型糖尿病,且已确诊CVD(既往心肌梗死、中风或外周动脉疾病)。通过连续年度横断面数据组建患病率和发病率队列,并绘制HCRU、成本和特定事件的发病率。使用马尔可夫模型对CVD和死亡率轨迹进行建模。将HCRU和成本叠加到该模型上以获得相关轨迹。
2019年,高BMI且已确诊CVD的个体(n = 27313)的人均年度医疗成本为3364英镑。在2015 - 2019年期间,主要不良CV事件的发生率为每10万人年2812例;全因死亡率和CV死亡率分别为每10万人年2896例和774例。在2022 - 2031年期间,该人群预计将产生估计4080万英镑的医疗成本。HCRU轨迹的驱动因素包括CV事件史、年龄较大和多种疾病并存。
由于疾病和治疗负担较重,有CVD病史且BMI较高的人群产生了大量医疗成本,并有死亡风险。